BRETSCHER, 2009 - Google Patents
Molecular architecture of the microvillusBRETSCHER, 2009
- Document ID
- 3781144895889816060
- Author
- BRETSCHER A
- Publication year
- Publication venue
- Brush Border Membranes
External Links
Snippet
This study deals with the molecular organization and function of the components of filament core bundles in intestinal epithelial microvilli. The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (M, 43 000) that makes up the filaments, the villin (M …
- 210000000110 Microvilli 0 title abstract description 162
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Taniuchi et al. | Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties | |
| Joliot et al. | Antennapedia homeobox peptide regulates neural morphogenesis. | |
| Rao et al. | Evidence that α-crystallin prevents non-specific protein aggregation in the intact eye lens | |
| Rada et al. | Proteoglycans in the human sclera. Evidence for the presence of aggrecan. | |
| Craig et al. | Regulation of actin polymerization by villin, a 95,000 dalton cytoskeletal component of intestinal brush borders | |
| Lemons et al. | Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord | |
| Hewitt et al. | Photoreceptor survival-promoting activity in interphotoreceptor matrix preparations: characterization and partial purification | |
| DE3689191T2 (en) | PURIFIED PROTEIN WITH ANGIOGENIC EFFECT AND THE PRODUCTION THEREOF. | |
| Piehl et al. | Calcitonin gene‐related peptide (CGRP)‐like immunoreactivity and CGRP mRNA in rat spinal cord motoneurons after different types of lesions | |
| US20100268336A1 (en) | Materials and Method for Promotion of Nerve Regeneration | |
| JPH10505238A (en) | Nutritional factors for central nervous system regeneration | |
| Li et al. | Association of a cellular myosin II with anionic phospholipids and the neuronal plasma membrane. | |
| Caffé et al. | Photoreceptor-specific protein expression of mouse retina in organ culture and retardation of rd degeneration in vitro by a combination of basic fibroblast and nerve growth factors | |
| Andrews et al. | Single kinesin molecules crossbridge microtubules in vitro. | |
| DE69433243T2 (en) | Use of ApoE to bind TAU and MAP2c proteins and to treat Alzheimer's disease | |
| CHONG et al. | An immunohistochemical study of an autosomal dominant feline rod/cone dysplasia (Rdy cats) | |
| Parry et al. | The effect of reinnervation on the distribution of muscle fibre types in the tibialis anterior muscle of the mouse | |
| BRETSCHER | Molecular architecture of the microvillus | |
| Kato et al. | Gliotoxic effects of α-aminoadipic acid isomers on the carp retina: a long term observation | |
| Franchi et al. | Subcellular localization of newly incorporated myosin in rabbit fast skeletal muscle undergoing stimulation-induced type transformation | |
| US7833977B2 (en) | Use of L-Carnitine as stabilizing agent of proteins | |
| Blau et al. | Morphogenesis of the silkmoth chorion: Patterns of distribution and insolubilization of the structural proteins | |
| US20020142954A1 (en) | Laminin 15 and uses thereof | |
| Bush et al. | Blood‐nerve barrier: ultrastructural and endothelial surface charge alterations following nerve crush | |
| US5891847A (en) | Treatment of degenerative eye disorders |